Soy isoflavones and bone health: a double-edged sword?
Numerous publications and research studies on isoflavones have prompted a nationwide increase in the consumption of soy-based foods and supplements in the United States. Isoflavones are natural endocrine active compounds generally considered to promote health and prevent or slow the onset of certain chronic diseases such as osteoporosis. The beneficial effects of soy isoflavones on bone may, however, be life-stage specific and dependent on the estrogen receptor number and endogenous hormone milieu. Perimenopausal and early menopausal women may therefore be more receptive to the therapeutic effects of isoflavones on bone loss prior to the diminution of estrogen receptors that occurs in the postmenopausal years, whereas laboratory studies in developmental age range animals have demonstrated the potential for adverse effects following exposure to high levels of soy isoflavones. Clinical studies in developing humans that either support or refute findings in animal studies are lacking. The effects of chronic consumption of high levels of soy isoflavones at each life stage to assess risk-benefit ratios should be a high priority of research.
Department of Food Science, Purdue University, West Lafayette, Indiana 47907-2009, USA.
Susan
S
Reinwald
Connie M
CM
Weaver
D000818:Animals; D001847:Bone Diseases / Q000517:prevention & control*; D001842:Bone and Bones / Q000502:physiology*; D005260:Female; D006262:Health; D006801:Humans; D007529:Isoflavones; D008593:Menopause; D015663:Osteoporosis, Postmenopausal / Q000453:epidemiology / Q000517:prevention & control; D048789:Phytoestrogens; D051381:Rats; D011960:Receptors, Estrogen; D045730:Soy Foods; D014481:United States
D007529:Isoflavones; D048789:Phytoestrogens; D011960:Receptors, Estrogen